Showing results (4351-4360 of 27,715) with videos related to
Sort By:
Pageof 2,772
Vaccine|May 21, 2011
Bacterial etiology and serotypes of acute otitis media in Mexican childrenMercedes Macias Parra, Gerardo Martinez Aguilar, Gabriela Echaniz-Aviles, et al.Vaccine|May 21, 2011
HIV-Gag VLPs presenting trimeric HIV-1 gp140 spikes constitutively expressed in stable double transfected insect cell lineM Tagliamonte, M L Visciano, M L Tornesello, et al.Vaccine|March 17, 2011
GP120-specific exosome-targeted T cell-based vaccine capable of stimulating DC- and CD4(+) T-independent CTL responsesRoopa Hebbandi Nanjundappa, Rong Wang, Yufeng Xie, et al.Vaccine|March 17, 2011
Italian post-marketing surveillance for adverse event reports after MF59-adjuvanted H1N1v vaccinationElisabetta Parretta, Benedetta Ianniello, Fernanda Ferrazin, et al.Vaccine|March 17, 2011
Mutations affecting the stability of the haemagglutinin molecule impair the immunogenicity of live attenuated H3N2 intranasal influenza vaccine candidates lacking NS1Sabine Nakowitsch, Markus Wolschek, Alexander Morokutti, et al.Vaccine|March 8, 2011
Human papillomavirus vaccine uptake and barriers: association with perceived risk, actual risk and race/ethnicity among female students at a New York State university, 2010Robert A Bednarczyk, Guthrie S Birkhead, Dale L Morse, et al.Vaccine|March 8, 2011
Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challengeParthiban Rajasekaran, Naveen Surendran, Mohamed N Seleem, et al.Vaccine|March 1, 1990
Controlling hepatitis B virus transmission in North America. The North American Regional Study GroupF B HollingerVaccine|March 1, 1990
Immunogenicity of a recombinant DNA hepatitis B vaccine in institutionalized patients with Down's syndromeP Van Damme, R Vranckx, A MeheusVaccine|March 1, 1990
Development and production aspects of a recombinant yeast-derived hepatitis B vaccineJ StephennePageof 2,772